Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies

Immunotherapy is an effective treatment in advanced cancer, although predictors of response are limited. We studied whether excess weight influences the efficacy outcomes of immunotherapy. We have also evaluated the combined prognostic effect of excess weight and immune-related adverse events (irAEs...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogado, Jacobo, Romero-Laorden, Nuria, Sanchez-Torres, José Miguel, Ramos-Levi, Ana María, Pacheco-Barcia, Vilma, Ballesteros, Ana Isabel, Arranz, Reyes, Lorenzo, Alicia, Gullon, Pedro, Garrido, Ana, Serra López-Matencio, José María, Donnay, Olga, Adrados, Magdalena, Costas, Pablo, Aspa, Javier, Alfranca, Arantzazu, Mondejar, Rebeca, Colomer, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185216/
https://www.ncbi.nlm.nih.gov/pubmed/32363123
http://dx.doi.org/10.1080/2162402X.2020.1751548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185216/
https://www.ncbi.nlm.nih.gov/pubmed/32363123
http://dx.doi.org/10.1080/2162402X.2020.1751548

Ejemplares similares